Detalles de la búsqueda
1.
Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines.
Int J Mol Sci
; 24(19)2023 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37833990
2.
In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking.
Int J Mol Sci
; 23(7)2022 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35409348
3.
Anti-epileptic activity, toxicity and teratogenicity in CD1 mice of a novel valproic acid arylamide derivative, N-(2-hydroxyphenyl)-2-propylpentanamide.
Toxicol Appl Pharmacol
; 399: 115033, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32387339
4.
Decrease in Cell Viability of Breast Cancer Cells by a Di-Hydroxylated Derivative of N-(2-hydroxyphenyl)-2-Propylpentanamide.
Anticancer Agents Med Chem
; 22(9): 1802-1812, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34525926
5.
Apoptotic Effects of N-(2-Hydroxyphenyl)-2-Propylpentanamide on U87-MG and U-2 OS Cells and Antiangiogenic Properties.
Anticancer Agents Med Chem
; 21(11): 1451-1459, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32723256
6.
Exploring the biotransformation of N-(2-hydroxyphenyl)-2-propylpentanamide (an aryl valproic acid derivative) by CYP2C11, using in silico predictions and in vitro studies.
J Pharm Pharmacol
; 72(7): 938-955, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32307724
Resultados
1 -
6
de 6
1
Próxima >
>>